Less is more meets do more with less: Exploring differences in thyroid FNA molecular testing between Asian and Western practices
- PMID: 36973996
- DOI: 10.1002/cncy.22700
Less is more meets do more with less: Exploring differences in thyroid FNA molecular testing between Asian and Western practices
Comment in
-
Thyroid FNA cytology: The Eastern versus Western perspectives.Cancer Cytopathol. 2023 Jul;131(7):415-420. doi: 10.1002/cncy.22692. Epub 2023 Mar 27. Cancer Cytopathol. 2023. PMID: 36973997 No abstract available.
References
REFERENCES
-
- Cibas ES. We are minimally invasive diagnosis. J Am Soc Cytopathol. 2021;10(2):113-114. doi:10.1016/j.jasc.2020.12.005
-
- Pusztaszeri MP, Krane JF, Faquin WC. BRAF testing and thyroid FNA. Cancer Cytopathol. 2015;123(12):689-695. doi:10.1002/cncy.21614
-
- Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12(2):245-262. doi:10.1677/erc.1.0978
-
- Trimboli P, Treglia G, Condorelli E, et al. BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis. Clin Endocrinol. 2016;84(3):315-320. doi:10.1111/cen.12806
-
- Brigante G, Craparo A, Pignatti E, et al. Real-life use of BRAF-V600E mutation analysis in thyroid nodule fine needle aspiration: consequences on clinical decision-making. Endocrine. 2021;73(3):625-632. doi:10.1007/s12020-021-02693-2
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
